Cherry eye surgery costs $500-$1,500 per eye - and often affects both eyes. The third eyelid gland prolapses outward, creating a red swollen bulge. Surgery to tuck the gland back is the standard fix. The sooner it's done, the better the outcome.
What Is Cherry Eye
Dogs have a third eyelid with a tear-producing gland. When connective tissue fails, the gland prolapses outward, creating a red fleshy bulge. This weakness is typically genetic. Most common in dogs under 2 years old
Symptoms What to Watch For
A pink or red, smooth, oval mass protrudes from the inner corner. Excessive eye watering or mucus discharge may occur. Dogs often paw at the affected eye. Redness and swelling around the eye develops. The mass may initially come and go before becoming permanent. Usually appears suddenly
Diagnosis $50-$100
Cherry eye is diagnosed by visual examination - the prolapsed gland is obvious. Vets check for secondary issues like corneal ulcers or dry eye. A Schirmer tear test ($20-$40) may measure tear production. No advanced imaging needed. Average $50-$100
Treatment Surgery $500-$1,500/eye
The preferred surgery is pocket technique (Morgan pocket) - the gland tucks back into a pocket, preserving tear production. Gland removal risks chronic dry eye. Post-surgery anti-inflammatory drops prescribed. Some cases need a second surgery if re-prolapse occurs. Average $500-$1,500
Total Cost $600-$3,200
Exam plus surgery. If both eyes are affected (common), expect $1,200-$3,200 total.
Brachycephalic Breeds Higher Risk
Recovery 2-4 Weeks
E-collar required to prevent rubbing. Eye drops for 2-4 weeks. Most dogs heal fully with no complications.
Prevention
No known prevention - it's genetic. Buy from breeders who screen for eye problems in their lines.
The Real Cost
$600typical cost
Exam plus surgery.
Diagnosis $50-$100
Treatment $500-$1,500/eye
Total Cost $600-$3,200
Red flags
Insurance Traps
Cherry eye surgery is a common claim. But bilateral cases complicate coverage.
Cherry Eye Coverage Basics Waiting period
Most policies cover cherry eye surgery as a standard illness after enrollment. The 14-day illness waiting period applies. First occurrence in one eye is typically covered - surgery, anesthesia, medication, and follow-ups included.
The Bilateral Eye Trap Bilateral
If one eye develops cherry eye, the second often follows. Some insurers classify the second eye as related to the first - potentially pre-existing or one deductible total. Others treat each eye independently. Clarify before the second eye prolapses.
Cost vs Deductible Deductible
Surgery at $500-$1,500 per eye typically exceeds your deductible. Bilateral surgery can reach $3,200. With 80% reimbursement and $500 deductible, you save $400-$2,100 depending on coverage.
Breed-Specific Exclusions Exclusion
Some insurers add breed-specific exclusions for conditions common in certain breeds. While most cover cherry eye, some exclude it for Bulldogs and high-risk breeds. Read fine print on breed-related exclusions before enrolling.
Common Questions
Real answers about costs, treatment, and insurance coverage.
What does cherry eye look like in dogs?
A pink or red, smooth, oval mass protrudes from the inner corner of the eye - resembling a small cherry. Size varies from barely noticeable to partially covering the eye. It may pop in and out initially before becoming permanently prolapsed.
How much does cherry eye surgery cost?
Typically $500-$1,500 per eye including exam, anesthesia, surgical procedure (pocket/tuck technique), and post-op medications. Simultaneous bilateral surgery: $800-$2,500. Follow-up visits add $50-$100. Second surgery for re-prolapse costs the full amount.
Can cherry eye go away on its own?
Rarely. The gland may pop in and out early, appearing to resolve, but almost always becomes permanently prolapsed. Massaging it back is temporary. Surgery is the only reliable fix. Delaying risks chronic irritation, dry eye, and corneal damage.
Is cherry eye surgery necessary?
Yes. The prolapsed gland produces 30-50% of tear fluid. Untreated, it becomes chronically inflamed and may lose function, causing dry eye (KCS) - painful and requiring lifelong treatment. Longer prolapse makes surgery harder and recurrence risk higher.
Can cherry eye come back after surgery?
Yes. The pocket technique succeeds 90-95% of the time; 5-10% may re-prolapse. Bulldogs and Neapolitan Mastiffs have higher recurrence rates. Second surgery is needed if re-prolapse occurs. Gland removal is a last resort but causes chronic dry eye.
Does cherry eye affect both eyes?
Often yes. The underlying connective tissue weakness is genetic and typically affects both eyes. The second eye may follow weeks or months later, or develop simultaneously. Some owners opt for bilateral surgery at the same time to save on anesthesia costs.
What breeds are most prone to cherry eye?
Flat-faced breeds most commonly: English Bulldogs, French Bulldogs, Beagles, Cocker Spaniels, Shih Tzus, Pugs, and Boston Terriers. Bloodhounds, Neapolitan Mastiffs, and Cane Corsos are also frequently affected. Typically appears in dogs under 2 years of age.
Does pet insurance cover cherry eye surgery?
Most policies cover cherry eye surgery as a standard illness - 14-day waiting period applies. Coverage for the second eye varies: some treat both as one condition, others as separate claims. Enroll before symptoms appear - typically shows within two years.
My mother-in-law's boxer. Problem. $1,200 in tests, no answers. Another vet solved it with $8 pills. When you're scared, you'll pay anything - and some vets price accordingly. So I built what I couldn't find: real costs, real exclusions, plain language. Not selling policies.
Sources
Research and data used to compile this profile.
- 1 Plummer CE, Källberg ME, Gelatt KN, et al. Intranictitans tacking for replacement of prolapsed gland of the nictitating membrane in dogs. Vet Ophthalmol. 2008;11(4):228-33.
- 2 Sapienza JS, Mayordomo A, Beyer AM. Suture anchor placement technique around the insertion of the ventral rectus muscle for the replacement of the prolapsed gland of the third eyelid in dogs: 100 dogs. Vet Ophthalmol. 2014;17(2):81-6.